Side-by-side financials for CCCC and BNTX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CCCC | BNTX |
|---|---|---|
| Market cap | - | $22.64 B |
| US-listed rank | - | #570 |
| Revenue (latest FY) | $35.95M | - |
| Net income (latest FY) | -$104.99M | - |
| Net margin | -292.1% | - |
| SEC filings | 516 | 548 |
Full pages: C4 Therapeutics, Inc. and BioNTech SE, or browse the full rankings.